JSPR
Jasper Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Jasper Therapeutics (JSPR) Stock: Buy, Sell, or Hold?
$14.76
+0.01 (+0.07%)
▲
5d:
+2787.89%
30d:
+2878.21%
90d:
+1610.11%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (16%)
Quality Score
32/100
Position
EXTENDED
30-Day Fair Range
$-2.63 – $8.01
Position: EXTENDED
Forward P/E & Valuation
-0.7x
Next 12M consensus est.
Wall Street Target
$600.00
+3965.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.44 / $17.03
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: JSPR is 84.3% above its trading range ($8.01). While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When JSPR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: JSPR is currently trading at $14.76, which is considered extended relative to its 30-day fair value range of $-2.63 to $8.01.
Technical Outlook: Technically, JSPR is in a uptrend. Immediate support is located at $0.44, while resistance sits at $17.03.
Market Sentiment: JSPR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $600.00 (+3965.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, JSPR is in a uptrend. Immediate support is located at $0.44, while resistance sits at $17.03.
Market Sentiment: JSPR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $600.00 (+3965.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-2.63 -
$8.01
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
15.8%
Trading Range & Key Levels
30-Day Trading Range
$-2.63 -
$8.01
Current vs Trading Range
EXTENDED
Support Level
$0.44
Resistance Level
$17.03
Current Trend
Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price significantly overextended (+84.3% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 3965.0% below Wall St target ($600.00)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.70
Wall Street Target
$600.00
(+3965.0%)
Share JSPR Analysis
Share this live JSPR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (JSPR)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 28, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message from a user with 135 followers expresses optimism about $JSPR, citing numerous analyst upgrades and a strong buy rating. No recent Yahoo Finance news articles were found.
Key Retail Themes:
analyst upgrades
buy rating
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:56 AM ET
Data refreshes hourly during market hours. Next update: 8:56 AM
Data refreshes hourly during market hours. Next update: 8:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JSPR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 35 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 62 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive JSPR Research Pages
